Active Ingredient
Polyethylene Glycol 3350, 17 g (cap filled to line)
The following Structured Product Label (SPL) was submitted to the FDA by Lupin Pharmaceuticals,inc. for the product Gavilax (NDC 43386-312). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, warnings, ask a doctor before use if you have, stop use and ask a doctor if, keep out of the reach of children, directions, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Polyethylene Glycol 3350, 17 g (cap filled to line)
Osmotic Laxative
Use
Allergy alert: Do not use if you are allergic to polyethylene glycol
Do not use if you have kidney disease, except under the advice and supervision of a doctor
Ask a doctor or pharmacist before use if you are taking a prescription drug
When using this product you may have loose, watery, more frequent stools
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a POISON CONTROL CENTER right away. (1-800-222-1222)
Other Information
none
1-866-403-7592
NDC 43386-312-08
Original Prescription Strength
GaviLax
Polyethylene Glycol 3350
Powder for Solution, Osmotic Laxative
14 ONCE-DAILY DOSES
NET WT 8.3 OZ (238 g)
NDC 43386-312-85
Original Prescription Strength
GaviLax
Polyethylene Glycol 3350
Powder for Solution, Osmotic Laxative
50 ONCE-DAILY DOSES
NET WT 29.9 OZ (850 g)
* Please review the disclaimer below.